Description
产品说明
| 所属分类 | 微生物 > 模式菌株 |
|---|---|
| 品牌 / 来源 | CS-BIC | 中科生信 |
| 应用 | 科研，生产，产生细胞毒素,肠内研究 |
| 培养基 | ATCC® Medium 2107: Modified Reinforced Clostridial ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| 存储人 | FE Clark |
| 出品公司 | ATCC |
| 参考文献 | Rolfe RD, Finegold SM. Purification and characterization of Clostridium difficile toxin. Infect. Immun. 25: 191-201, 1979. PubMed: 478634 Florin I, Thelestam M. Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin. Infect. Immun. 33: 67-74, 1981. PubMed: 6167521 Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Rupnik, M et al. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J. Clin. Microbiol. 36(8): 2240-2247, 1998. PubMed: 9665999 Fawley WN, Wilcox MH; on behalf of the Clostridium difficile Ribotyping Network for England and N. Ireland (CDRN). An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR-ribotype. J. Clin. Microbiol. 49(12): 4333-4337, 2011. PubMed: 21956986 Lemee L, et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J. Clin. Microbiol. 42(12): 5710-5714, 2004. PubMed: 15583303 Rupnik, M et al. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J. Clin. Microbiol. 36(8): 2240-2247, 1998. PubMed: 9665999 Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Rupnik, M et al. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J. Clin. Microbiol. 36(8): 2240-2247, 1998. PubMed: 9665999 |
| 模式菌株 | 是 |
| 生长条件 | 37 ℃, 厌氧气体混合物,80% N2 -10% CO2 -10% H2 |
| 菌株特点 | ATCC 9689 Clostridium difficile ,艰难梭菌。 Nucleotide (GenBank) : X94328 C.difficile spo0A gene. Nucleotide (GenBank) : AX110003 Sequence 736 from Patent WO0123604. Nucleotide (GenBank) : AX110007 Sequence 740 from Patent WO0123604. Nucleotide (GenBank) : AX110095 Sequence 828 from Patent WO0123604. Nucleotide (GenBank) : AX111484 Sequence 2217 from Patent WO0123604. Nucleotide (GenBank) : AX111505 Sequence 2238 from Patent WO0123604. Nucleotide (GenBank) : AX111525 Sequence 2258 from Patent WO0123604. Nucleotide (GenBank) : U36481 Clostridium difficile sporulation protein homolog (spo0A) gene, partial cds. Nucleotide (GenBank) : S51968 {16S/23S ribosomal DNA spacer region} [Clostridium difficile, ATCC 9689, Genomic, 271 nt] Nucleotide (GenBank) : U43514 Clostridium difficile putative spoIVB (spoIVB) gene, complete cds, and phosphorylation-activated transcription factor spo0A (spo0a) gene, complete cds. |
| 菌株类型 | Clostridium difficile ,艰难梭菌 |
| 菌种又名 | 90556-M6S [L.S. McClung 1780] |
| 菌种名称 | ATCC 9689, ATCC9689 |
| 产品目录号 | 9689 |
| 生物安全等级 | 2 |
| 其他保藏库编号 | ATCC 9689 |
| ATCC9689标准菌株基本信息 | ATCC ATCC 9689, ATCC9689 90556-M6S [L.S. McClung 1780] Clostridium difficile ,艰难梭菌 FE Clark 9689 ATCC 9689 ATCC® Medium 2107: Modified Reinforced Clostridial ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood 37 ℃, 厌氧气体混合物,80% N2 -10% CO2 -10% H2 2 是 科研，生产，产生细胞毒素,肠内研究 ATCC 9689 Clostridium difficile ,艰难梭菌。 Nucleotide (GenBank) : X94328 C.difficile spo0A gene. Nucleotide (GenBank) : AX110003 Sequence 736 from Patent WO0123604. Nucleotide (GenBank) : AX110007 Sequence 740 from Patent WO0123604. Nucleotide (GenBank) : AX110095 Sequence 828 from Patent WO0123604. Nucleotide (GenBank) : AX111484 Sequence 2217 from Patent WO0123604. Nucleotide (GenBank) : AX111505 Sequence 2238 from Patent WO0123604. Nucleotide (GenBank) : AX111525 Sequence 2258 from Patent WO0123604. Nucleotide (GenBank) : U36481 Clostridium difficile sporulation protein homolog (spo0A) gene, partial cds. Nucleotide (GenBank) : S51968 {16S/23S ribosomal DNA spacer region} [Clostridium difficile, ATCC 9689, Genomic, 271 nt] Nucleotide (GenBank) : U43514 Clostridium difficile putative spoIVB (spoIVB) gene, complete cds, and phosphorylation-activated transcription factor spo0A (spo0a) gene, complete cds. Rolfe RD, Finegold SM. Purification and characterization of Clostridium difficile toxin. Infect. Immun. 25: 191-201, 1979. PubMed: 478634 Florin I, Thelestam M. Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin. Infect. Immun. 33: 67-74, 1981. PubMed: 6167521 Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Rupnik, M et al. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J. Clin. Microbiol. 36(8): 2240-2247, 1998. PubMed: 9665999 Fawley WN, Wilcox MH; on behalf of the Clostridium difficile Ribotyping Network for England and N. Ireland (CDRN). An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR-ribotype. J. Clin. Microbiol. 49(12): 4333-4337, 2011. PubMed: 21956986 Lemee L, et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J. Clin. Microbiol. 42(12): 5710-5714, 2004. PubMed: 15583303 Rupnik, M et al. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J. Clin. Microbiol. 36(8): 2240-2247, 1998. PubMed: 9665999 Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Rupnik, M et al. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J. Clin. Microbiol. 36(8): 2240-2247, 1998. PubMed: 9665999 |
Related
